From ISIS recent presentation -
KYNAMRO is in many ways a validation of everything
we have created at Isis – a unique drug discovery platform
(antisense), a maturing pipeline, and a business strategy
that has made this exciting time in Isis’ history possible.
Our pipeline is broad, deep and growing, and it represents
the future beyond KYNAMRO.
The success of KYNAMRO combined
with the success of many of the other drugs in our pipeline
gives us great optimism that we can bring our novel
business model to fruition.
anp in the big picture of isis?
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $41.90K | 409.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 391487 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 116101 | 4 |
View Market Depth
| Last trade - 13.10pm 27/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |